IGF-1 LR3
Long R3 Insulin-like Growth Factor-1
IGF-1 LR3 is a synthetic analog of human insulin-like growth factor 1, engineered with an arginine substitution at position 3 and 13 additional amino acids at the N-terminus. This 83-amino acid peptide exhibits reduced affinity for IGF-binding proteins, resulting in a prolonged half-life of 20-30 hours and approximately 3 times greater potency than native IGF-1. Currently investigational and not FDA-approved for human use.
Daily Implementation Guide
Daily Implementation Schedule
Lifestyle Integration Strategies
Nutrition Optimization
- â˘High-protein meals (30-40g per meal)
- â˘Eat slowly to enhance satiety effects
- â˘Stay hydrated (3+ liters daily)
- â˘Avoid high-fat meals on injection day
Exercise Enhancement
- â˘Start with 150 min moderate exercise weekly
- â˘Resistance training 2-3x per week
- â˘Monitor energy levels during escalation
- â˘Adjust intensity based on side effects
Sleep & Recovery
- â˘Maintain consistent sleep schedule
- â˘Monitor for sleep quality improvements
- â˘Track energy levels throughout day
- â˘Adjust injection timing if affecting sleep
Progress Tracking
SUCCESS MILESTONES
Medical Disclaimer
IGF-1 LR3 is an investigational research compound not approved by the FDA for human therapeutic use. This information is provided for educational purposes only and should not be construed as medical advice. IGF-1 LR3 carries significant risks including severe hypoglycemia and potential tumor growth acceleration. Any use should only occur under strict medical supervision in approved research settings. Individuals with cancer history, diabetes, or other serious medical conditions should not use this compound.